The European Medicines Agency will hold an extraordinary meeting to decide whether Pfizer’s coronavirus vaccine should be allowed
As News Front reported earlier, the United Kingdom was the first country to allow vaccination with the American-made vaccine. The first side effects appeared there too. Allergy sufferers faced problems and were even advised to abstain from vaccination.
Additionally, in the US, where the Pfizer vaccine is already actively used, authorities have registered thousands of “health related incidents. However, no details have been given.
The EU will consider registering the vaccine at a meeting on Monday 21 December. Experts from the European Medicines Agency have been scrutinising data provided by the drug’s manufacturer in recent days.
“The extent of progress depends on a robust and complete assessment of quality, safety and efficacy and is determined by the availability of further information from the company to answer questions posed in the evaluation”, – the agency said.
If the vaccine is approved, the European Commission will speed up the decision-making process so that approval will soon spread to all member states of the commonwealth.